Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.
Shanafelt T, Zent C, Byrd J, Erlichman C, Laplant B, Ghosh A, Call T, Villalona-Calero M, Jelinek D, Bowen D, Laumann K, Wu W, Hanson C, Kay N.
Shanafelt T, et al.
Leuk Lymphoma. 2010 Dec;51(12):2222-9. doi: 10.3109/10428194.2010.524327. Epub 2010 Nov 5.
Leuk Lymphoma. 2010.
PMID: 21054149
Free PMC article.
Clinical Trial.